Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-94887-x, published online 28 July 2021
The Acknowledgements section in the original version of this Article was incomplete.
“Yolanda Hartman, Sheila Bright, Catherine Langford, Sharon Samuel, Erika McMillian, Brian Wright, Lauren Radford, Charlotte Jeffers, Jennifer Bartels, Tolulope Aweda, Jonathan McConathy, **da Fan, Norio Yasui, Dattatray Devalankar, Himani Modi, Morgan Richardson, and staff of the University of Alabama Cyclotron Facility are gratefully acknowledged for their contributions and informative discussions. Funding was provided by the National Institutes of Health/National Institute of Neurological Disorders and Stroke T32 UAB Training Program in Brain Tumor Biology (T32 NS048039), the UAB Brain Tumor Core Facility (USPHS NCI P20CA151129), the National Center for Advancing Translational Research of the National Institutes of Health (UL1TR001417), the American Cancer Society (RSG-18-006-01-CCE), National Cancer Institute (R01CA24058) and the Comprehensive Cancer Center at UAB (NIH P30CA013148). JWL is supported by funding from the Department of Defense (W81XWH-18-1-0315) and National Institutes of Health (R01AI148711). JMW is supported by the Department of Defense (RCRP CA170769). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
now reads:
“Yolanda Hartman, Sheila Bright, Catherine Langford, Sharon Samuel, Erika McMillian, Brian Wright, Lauren Radford, Charlotte Jeffers, Jennifer Bartels, Tolulope Aweda, Jonathan McConathy, **da Fan, Norio Yasui, Dattatray Devalankar, Himani Modi, Morgan Richardson, and staff of the University of Alabama Cyclotron Facility are gratefully acknowledged for their contributions and informative discussions. Funding was provided by the National Institutes of Health/National Institute of Neurological Disorders and Stroke T32 UAB Training Program in Brain Tumor Biology (T32 NS048039), the UAB Brain Tumor Core Facility (USPHS NCI P20CA151129), the National Center for Advancing Translational Research of the National Institutes of Health (UL1TR001417), the American Cancer Society (RSG-18-006-01-CCE), National Cancer Institute (R01CA24058). This was supported by the Preclinical Imaging Facility at the O’Neal Comprehensive Cancer Center at UAB (NIH P30CA013148). JWL is supported by funding from the Department of Defense (W81XWH-18-1-0315) and National Institutes of Health (R01AI148711). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kasten, B.B., Houson, H.A., Coleman, J.M. et al. Author Correction: Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model. Sci Rep 11, 20450 (2021). https://doi.org/10.1038/s41598-021-00042-x
Published:
DOI: https://doi.org/10.1038/s41598-021-00042-x
- Springer Nature Limited